Anzeige
Mehr »
Login
Sonntag, 23.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A117UE | ISIN: US5165441032 | Ticker-Symbol: 0L8
Tradegate
21.02.25
21:42 Uhr
74,82 Euro
+0,04
+0,05 %
1-Jahres-Chart
LANTHEUS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LANTHEUS HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
74,0275,5222.02.
73,6475,9221.02.

Aktuelle News zur LANTHEUS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.02.Lantheus Holdings, Inc.: Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting16
04.02.Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now9
30.01.Lantheus Holdings, Inc.: Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member3
29.01.Lantheus acquires radiopharma CDMO Evergreen for up to $1bn5
29.01.Why Lantheus Holdings Stock Got Thrashed on Tuesday4
LANTHEUS Aktie jetzt für 0€ handeln
28.01.Lantheus Shares Down Nearly 9% On News Of Evergreen Theragnostics Acquisition11
28.01.Lantheus lays out $250M+ to get its hands on radiopharma developer and CDMO Evergreen4
28.01.Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio2
28.01.Lantheus Holdings to Acquire Evergreen Theragnostics4
28.01.Evergreen Theragnostics, Inc.: Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader86Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilitiesAdds OCTEVY, a registrational-stage diagnostic...
► Artikel lesen
28.01.Lantheus To Acquire Evergreen Theragnostics; Reaffirms Guidance6
28.01.Lantheus to acquire Evergreen Theragnostics2
28.01.Lantheus Holdings, Inc.: Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader88Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY, a registrational-stage diagnostic asset...
► Artikel lesen
28.01.Lantheus Holdings, Inc. - 8-K, Current Report-
16.01.Lantheus To Buy Life Molecular Imaging For Upfront Payment Of $350 Million7
14.01.What 4 Analyst Ratings Have To Say About Lantheus Holdings3
14.01.Lantheus Holdings, Inc. (LNTH): A Bull Case Theory5
13.01.Why Lantheus Holdings (LNTH) Stock Is Down 4%5
13.01.Lantheus to buy Life Molecular Imaging for $350M and additional payment on earn-outs1
13.01.Lantheus To Buy Neuraceq Owner Life Molecular Imaging For Upfront Payment Of $350 Mln1
Seite:  Weiter >>
71 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4